Overall rank by patents
#4,952
of 49,997 tracked assignees
USPTO PatentsView assignee record - 70 granted patents across 24 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).
The verdict
According to USPTO PatentsView, Integrated ranks #4,952 of 49,997 tracked US assignees by granted-patent volume, with 70 patents across 24 technology areas.
USPTO PatentsView assignee plate
Corpus R4952 · US Corporation #4,952 · 70 grants
GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL
Nearest grant-volume peer: Hermes Microvision Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Water Harvesting · near
51 score
Hiwin · near
51 score
Integrated DNA · this assignee
51 score
Invention And… · near
51 score
Nexperia B V · near
51 score
3D Lighting… · lowest
7 score
What this shows Integrated's Innovation Score is 51.2/100 (top 12% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Integrated DNA Technologies, Inc. is a focused PatentsView assignee: 24 CPC subclasses with 72.9% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2024 (15 grants) versus a trough of 1 in 2015. By volume, Integrated sits between Hermes Microvision Inc. and Lantiq Beteiligungs-gmbh & Co. KG.
Integrated DNA Technologies, Inc. shows 27 grants in 2022–2024 against only 16 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Hermes Microvision Inc.
70 patents
Hi-lex Corporation
70 patents
Hyundai Heavy Industries Co., Ltd.
70 patents
Industry-academia Cooperation Group OF Sejong University
70 patents
Intellectual Ventures Fund 79 LLC
70 patents
Johnson Health Tech Co., Ltd.
70 patents
Krohne AG
70 patents
Lantiq Beteiligungs-gmbh & Co. KG
70 patents
Integrated DNA Technologies, Inc.
70 patents
What this shows Integrated holds 70 patents at rank #4,952, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #4,952 in granted patent volume.
Other assignees with the most granted patents in Integrated's primary technology class.
Two PlainPatent-derived peer sets for Integrated, neither rank-band nor same-CPC leaders (those blocks stay above). In C12N (Microorganisms OR Enzymes), Integrated ranks #192 of 4,144 assignees by patent count in that subclass.
Nearest assignees by Innovation Score (51 here).
Nearest assignees by average claims per patent (13.2 here).
Integrated's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
51 Top 12% higher than 88% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 1 | 1.4% |
| 2016 | 7 | 10.0% |
| 2017 | 6 | 8.6% |
| 2018 | 7 | 10.0% |
| 2019 | 3 | 4.3% |
| 2020 | 6 | 8.6% |
| 2021 | 7 | 10.0% |
| 2022 | 6 | 8.6% |
| 2023 | 6 | 8.6% |
| 2024 | 15 | 21.4% |
| 2025partial year | 6 | 8.6% |
Top 15 of 24 technology areas
Overall rank by patents
#4,952
of 49,997 tracked assignees
51.2 out of 100
What to do with this data
Integrated DNA Technologies, Inc.'s patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.